Ocata Therapeutics Inc fka OCAT

[rumper]

OCAT Will Have Many More Employees in_The Future

Projecting the future trends with a straight edge is as effective
as analyzing a stock by comparing the low from the high.

Does it make any sense to hire the indians before the chief?
What would they do? Stand around until their chief was hired?

This new hire is being hired to take OCATs clinical capacity
from 4 in America, and 2 in Euope, to 20 and 10. This is
x5, or a quintupling of capacity.

And take RPE product inventory from thousands to millions.
This is OCATs plan for the Future.

This guy is being hired to implement the plan and hire his own
team. This is thoughtful management.

Ted: So the company, being the first, had to develop all the assays and all the testing that would be required to confirm that. The FDA has gone through, was comfortable, (IP, AS FAR AS THE EYE CAN IMAGINE) and as Eddy mentioned earlier, we've treated 38 patients safely. Again, safety, good IP, good protection, a lot of know-how that the rest of the market would have to try to catch up and find. Ultimately, once we confirm that they are RPE cells, we have methods to really support their further expansion, so that we can turn them into inventory for the treatment. This process oversimplifies, but sort of lays out what's currently about a 4 to 5 month process of the company and yields 1000 to 1200 doses of the therapy. All the trials that Eddy mentioned that we're going to be embarking on and supporting over the next two years will require about 200 doses. So as I mentioned earlier, this is a small company, but it controls its destiny. We've got the manufacturing piece down. We feel that we've got a lot of the foundation and the fundamentals of the technology very well mastered, and all we have to do now is do the work to show that we can make enough cells and enough doses to serve the entire market.



Roadshow 1.0